ROCKET PHARMACEUTICALS, INC.RCKTWEarnings & Financial Report
Nasdaq
RCKTW Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-52.2M
Net Profit
$-50.3M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.45
ROCKET PHARMACEUTICALS, INC. Q3 2025 Financial Summary
ROCKET PHARMACEUTICALS, INC. reported revenue of $0 for Q3 2025, with a net profit of $-50.3M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-50.3M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
ROCKET PHARMACEUTICALS, INC. Annual Revenue by Year
ROCKET PHARMACEUTICALS, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $566.3M | $499.4M | $446.4M | $393.7M | $527.7M | $471.1M | $421.0M | $368.0M |
| Liabilities | $73.8M | $57.9M | $61.8M | $63.9M | $64.5M | $58.9M | $66.8M | $54.4M |
| Equity | $492.6M | $441.5M | $384.6M | $329.8M | $463.2M | $412.1M | $354.2M | $313.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-29.3M | $-56.9M | $-53.8M | $-52.1M | $-46.9M | $-55.8M | $-49.0M | $-50.4M |